| __timestamp | Agios Pharmaceuticals, Inc. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 2917513 |
| Thursday, January 1, 2015 | 35992000 | 7878291 |
| Friday, January 1, 2016 | 50714000 | 8366794 |
| Sunday, January 1, 2017 | 71124000 | 6610381 |
| Monday, January 1, 2018 | 114145000 | 6556000 |
| Tuesday, January 1, 2019 | 132034000 | 6930000 |
| Wednesday, January 1, 2020 | 149070000 | 8758000 |
| Friday, January 1, 2021 | 121445000 | 10806000 |
| Saturday, January 1, 2022 | 121673000 | 9844000 |
| Sunday, January 1, 2023 | 119903000 | 13481000 |
| Monday, January 1, 2024 | 156784000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, Soleno Therapeutics, Inc. and Agios Pharmaceuticals, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. Agios Pharmaceuticals has seen a staggering 526% increase in SG&A costs from 2014 to 2023, peaking in 2020. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Soleno Therapeutics maintained a more conservative growth, with a 362% rise over the same period, indicating a more measured approach to scaling operations.
These trends underscore the diverse strategies employed by biotech firms in managing operational costs.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Bausch Health Companies Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.